EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia.
Angela E Rankine-MullingsCourtney R LittleMarvin E ReidDeanne P SoaresCarolyn Taylor-BryanJennifer M Knight-MaddenSusan E StuberAsha V BadalooKaren AldredMargaret E Wisdom-PhippsTeresa S LathamRussell E WarePublished in: JMIR research protocols (2016)
ClinicalTrials.gov NCT02556099; https://clinicaltrials.gov/ct2/show/NCT02556099 (Archived by WebCite at http://www.webcitation.org/6k1yMAa9G).